Cytomegalovirus Spread and Reactivation in Blood Cells
NCT00006314 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-05-13
Summary
To investigate the relationship between HCMV and bone marrow progenitor cells to understand whether HCMV is latent in CD34 + bone marrow progenitors and the mechanism by which the virus remains in a latent state.
Conditions
- Blood Disease
- Cytomegalovirus Infections
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Stephen St. Jeor · University of Nevada, Las Vegas
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-07-31
- Completion
- 2004-06-30
More Related Trials
-
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
NCT05683457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cytomegalovirus Control in Critical Care
NCT01503918 ·Status: COMPLETED ·Phase: PHASE2
-
Cytomegalovirus Cell-Mediated Immunity
NCT00815165 ·Status: COMPLETED
-
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
NCT04017962 ·Status: COMPLETED ·Phase: PHASE2
-
Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
NCT06520605 ·Status: RECRUITING
-
Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis
NCT04916704 ·Status: ACTIVE_NOT_RECRUITING
-
Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery
NCT02527291 ·Status: COMPLETED
-
A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada
NCT05571137 ·Status: COMPLETED
-
Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy
NCT04056533 ·Status: RECRUITING ·Phase: PHASE2
-
Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001531 ·Status: COMPLETED
-
Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients
NCT02268526 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 ·Status: COMPLETED
-
Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient
NCT03806764 ·Status: UNKNOWN ·Phase: NA
-
CMV Infection in Adolescent Males
NCT00302029 ·Status: TERMINATED
-
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
NCT01769170 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of CMV/EBV-CMI in Haploid HSCT
NCT06554197 ·Status: RECRUITING
-
Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
NCT01063829 ·Status: COMPLETED ·Phase: PHASE2
-
Cytomegalovirus Vaccine in Healthy Participants
NCT00712634 ·Status: COMPLETED ·Phase: PHASE1
-
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
NCT00530218 ·Status: COMPLETED ·Phase: PHASE2
-
Genotyping of Cytomegalovirus From Patients in Israel
NCT00228202 ·Status: UNKNOWN
-
A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection
NCT07141095 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614 ·Status: COMPLETED
-
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
NCT00509691 ·Status: COMPLETED ·Phase: PHASE1
-
Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)
NCT00330018 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China
NCT05958186 ·Status: COMPLETED